Complement System as a New Target for Hematopoietic Stem Cell Transplantation-Related Thrombotic Microangiopathy
Thrombotic microangiopathy (TMA) is a complication that may occur after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) and is conventionally called transplant-associated thrombotic microangiopathy (TA-TMA). Despite the many efforts made to understand the mechanisms of TA-TMA...
Saved in:
Main Authors: | Gianluigi Ardissino (Author), Valentina Capone (Author), Silvana Tedeschi (Author), Luigi Porcaro (Author), Massimo Cugno (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extrarenal manifestations of complement mediated thrombotic microangiopathies
by: Johannes eHofer, et al.
Published: (2014) -
Transplant-associated thrombotic microangiopathy
by: Tomasz Jarmoliński
Published: (2021) -
New-onset complement-mediated thrombotic microangiopathy during the COVID-19 pandemic
by: Christof Aigner, et al.
Published: (2024) -
Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management
by: Christopher C. Dvorak, et al.
Published: (2019) -
Transplant associated thrombotic microangiopathy: A transplanter 'S nightmare
by: Sunisha Arora, et al.
Published: (2024)